The CDC plans to allocate $1.6 million for a trial exposing newborns in Guinea-Bissau to hepatitis B, a risk that experts condemn as unethical and potentially life-threatening.
The CDC plans to allocate $1.6 million for a trial exposing newborns in Guinea-Bissau to hepatitis B, a risk that experts condemn as unethical and potentially life-threatening.